Johnson & Johnson CDR (CAD Hedged) (JNJ:TSX) closed at $34.42 on November 20, 2026, up 1.35% on the day. The stock trades 6.6% below its 52-week high of $36.87 and 31.5% above its 52-week low of $26.17. Over the past year, it gained 28.9%. Johnson & Johnson CDR (CAD Hedged) is part of the Health Care sector.
In 229 trading sessions since December 23, 2025, JNJ closed higher on 118 days (52%). Its best day was November 4, 2026 (+4.13%) and its worst was October 13, 2026 (-4.74%). It never moved 10% or more in a single session.
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.
Find more stocks like JNJ with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.